July 17, 2018, 9:42 am
Facebook iconTwitter iconYouTube iconGoogle+ icon
1 Philippine Peso = 0.06864 UAE Dirham
1 Philippine Peso = 2.00897 Albanian Lek
1 Philippine Peso = 0.03439 Neth Antilles Guilder
1 Philippine Peso = 0.50824 Argentine Peso
1 Philippine Peso = 0.02516 Australian Dollar
1 Philippine Peso = 0.03326 Aruba Florin
1 Philippine Peso = 0.03738 Barbados Dollar
1 Philippine Peso = 1.56345 Bangladesh Taka
1 Philippine Peso = 0.03139 Bulgarian Lev
1 Philippine Peso = 0.00707 Bahraini Dinar
1 Philippine Peso = 32.72248 Burundi Franc
1 Philippine Peso = 0.01869 Bermuda Dollar
1 Philippine Peso = 0.02526 Brunei Dollar
1 Philippine Peso = 0.1282 Bolivian Boliviano
1 Philippine Peso = 0.07195 Brazilian Real
1 Philippine Peso = 0.01869 Bahamian Dollar
1 Philippine Peso = 1.282 Bhutan Ngultrum
1 Philippine Peso = 0.19138 Botswana Pula
1 Philippine Peso = 374.13568 Belarus Ruble
1 Philippine Peso = 0.03734 Belize Dollar
1 Philippine Peso = 0.02459 Canadian Dollar
1 Philippine Peso = 0.01871 Swiss Franc
1 Philippine Peso = 12.14969 Chilean Peso
1 Philippine Peso = 0.12502 Chinese Yuan
1 Philippine Peso = 53.37133 Colombian Peso
1 Philippine Peso = 10.54401 Costa Rica Colon
1 Philippine Peso = 0.01869 Cuban Peso
1 Philippine Peso = 1.76603 Cape Verde Escudo
1 Philippine Peso = 0.4139 Czech Koruna
1 Philippine Peso = 3.31714 Djibouti Franc
1 Philippine Peso = 0.11919 Danish Krone
1 Philippine Peso = 0.92375 Dominican Peso
1 Philippine Peso = 2.19884 Algerian Dinar
1 Philippine Peso = 0.25015 Estonian Kroon
1 Philippine Peso = 0.3334 Egyptian Pound
1 Philippine Peso = 0.51037 Ethiopian Birr
1 Philippine Peso = 0.01599 Euro
1 Philippine Peso = 0.03902 Fiji Dollar
1 Philippine Peso = 0.01411 Falkland Islands Pound
1 Philippine Peso = 0.01412 British Pound
1 Philippine Peso = 0.08949 Ghanaian Cedi
1 Philippine Peso = 0.88526 Gambian Dalasi
1 Philippine Peso = 168.36105 Guinea Franc
1 Philippine Peso = 0.13998 Guatemala Quetzal
1 Philippine Peso = 3.87012 Guyana Dollar
1 Philippine Peso = 0.14665 Hong Kong Dollar
1 Philippine Peso = 0.44715 Honduras Lempira
1 Philippine Peso = 0.11858 Croatian Kuna
1 Philippine Peso = 1.25939 Haiti Gourde
1 Philippine Peso = 5.1596 Hungarian Forint
1 Philippine Peso = 268.604 Indonesian Rupiah
1 Philippine Peso = 0.06791 Israeli Shekel
1 Philippine Peso = 1.27993 Indian Rupee
1 Philippine Peso = 22.12671 Iraqi Dinar
1 Philippine Peso = 807.13885 Iran Rial
1 Philippine Peso = 2.0015 Iceland Krona
1 Philippine Peso = 2.42478 Jamaican Dollar
1 Philippine Peso = 0.01324 Jordanian Dinar
1 Philippine Peso = 2.09923 Japanese Yen
1 Philippine Peso = 1.87722 Kenyan Shilling
1 Philippine Peso = 1.27646 Kyrgyzstan Som
1 Philippine Peso = 75.63072 Cambodia Riel
1 Philippine Peso = 7.88806 Comoros Franc
1 Philippine Peso = 16.81929 North Korean Won
1 Philippine Peso = 21.08952 Korean Won
1 Philippine Peso = 0.00566 Kuwaiti Dinar
1 Philippine Peso = 0.01532 Cayman Islands Dollar
1 Philippine Peso = 6.39993 Kazakhstan Tenge
1 Philippine Peso = 157.01738 Lao Kip
1 Philippine Peso = 28.13493 Lebanese Pound
1 Philippine Peso = 2.97982 Sri Lanka Rupee
1 Philippine Peso = 2.97197 Liberian Dollar
1 Philippine Peso = 0.24762 Lesotho Loti
1 Philippine Peso = 0.05697 Lithuanian Lita
1 Philippine Peso = 0.0116 Latvian Lat
1 Philippine Peso = 0.02562 Libyan Dinar
1 Philippine Peso = 0.17688 Moroccan Dirham
1 Philippine Peso = 0.31088 Moldovan Leu
1 Philippine Peso = 0.98075 Macedonian Denar
1 Philippine Peso = 26.55578 Myanmar Kyat
1 Philippine Peso = 45.74846 Mongolian Tugrik
1 Philippine Peso = 0.15104 Macau Pataca
1 Philippine Peso = 6.63427 Mauritania Ougulya
1 Philippine Peso = 0.6382 Mauritius Rupee
1 Philippine Peso = 0.29097 Maldives Rufiyaa
1 Philippine Peso = 13.33283 Malawi Kwacha
1 Philippine Peso = 0.35287 Mexican Peso
1 Philippine Peso = 0.07569 Malaysian Ringgit
1 Philippine Peso = 0.24767 Namibian Dollar
1 Philippine Peso = 6.69034 Nigerian Naira
1 Philippine Peso = 0.58456 Nicaragua Cordoba
1 Philippine Peso = 0.15155 Norwegian Krone
1 Philippine Peso = 2.04691 Nepalese Rupee
1 Philippine Peso = 0.02764 New Zealand Dollar
1 Philippine Peso = 0.00719 Omani Rial
1 Philippine Peso = 0.01869 Panama Balboa
1 Philippine Peso = 0.06103 Peruvian Nuevo Sol
1 Philippine Peso = 0.06077 Papua New Guinea Kina
1 Philippine Peso = 1 Philippine Peso
1 Philippine Peso = 2.27135 Pakistani Rupee
1 Philippine Peso = 0.06898 Polish Zloty
1 Philippine Peso = 106.5969 Paraguayan Guarani
1 Philippine Peso = 0.06802 Qatar Rial
1 Philippine Peso = 0.07424 Romanian New Leu
1 Philippine Peso = 1.1686 Russian Rouble
1 Philippine Peso = 15.92992 Rwanda Franc
1 Philippine Peso = 0.07008 Saudi Arabian Riyal
1 Philippine Peso = 0.14699 Solomon Islands Dollar
1 Philippine Peso = 0.25089 Seychelles Rupee
1 Philippine Peso = 0.33555 Sudanese Pound
1 Philippine Peso = 0.16567 Swedish Krona
1 Philippine Peso = 0.02551 Singapore Dollar
1 Philippine Peso = 0.01412 St Helena Pound
1 Philippine Peso = 0.41499 Slovak Koruna
1 Philippine Peso = 153.24238 Sierra Leone Leone
1 Philippine Peso = 10.65221 Somali Shilling
1 Philippine Peso = 391.8333 Sao Tome Dobra
1 Philippine Peso = 0.16352 El Salvador Colon
1 Philippine Peso = 9.624 Syrian Pound
1 Philippine Peso = 0.24803 Swaziland Lilageni
1 Philippine Peso = 0.62213 Thai Baht
1 Philippine Peso = 0.04953 Tunisian Dinar
1 Philippine Peso = 0.04334 Tongan paʻanga
1 Philippine Peso = 0.09042 Turkish Lira
1 Philippine Peso = 0.12621 Trinidad Tobago Dollar
1 Philippine Peso = 0.57118 Taiwan Dollar
1 Philippine Peso = 42.3846 Tanzanian Shilling
1 Philippine Peso = 0.48981 Ukraine Hryvnia
1 Philippine Peso = 69.93085 Ugandan Shilling
1 Philippine Peso = 0.01869 United States Dollar
1 Philippine Peso = 0.58568 Uruguayan New Peso
1 Philippine Peso = 145.44945 Uzbekistan Sum
1 Philippine Peso = 2236.96505 Venezuelan Bolivar
1 Philippine Peso = 430.74192 Vietnam Dong
1 Philippine Peso = 2.06036 Vanuatu Vatu
1 Philippine Peso = 0.04858 Samoa Tala
1 Philippine Peso = 10.48103 CFA Franc (BEAC)
1 Philippine Peso = 0.05046 East Caribbean Dollar
1 Philippine Peso = 10.48103 CFA Franc (BCEAO)
1 Philippine Peso = 1.90563 Pacific Franc
1 Philippine Peso = 4.66922 Yemen Riyal
1 Philippine Peso = 0.24782 South African Rand
1 Philippine Peso = 96.98187 Zambian Kwacha
1 Philippine Peso = 6.76322 Zimbabwe dollar

Aquino: No rush, no protests on Dengvaxia

FORMER President Benigno Simeon Aquino III yesterday said there was no undue haste in the approval of the purchase of P3.5-billion worth of dengue vaccines during his administration. 

Aquino, during the resumption of the Senate blue ribbon committee hearings on the purchase of the Dengvaxia vaccines, also confirmed that he met with officials of Sanofi Pasteur, the vaccine’s manufacturer, twice but no one told him about the firm’s flecked record abroad or the issues against Dengvaxia.

The former president said he met with officials of the French pharmaceutical company on Dec. 1, 2015 while he was in Paris for the UN Conference on Climate Change. At the sidelines of the conference, he met businessmen from Vivapolis, Airbus, Jacobi, CRH, Usine IO and Sanofi.

It was then, he said, that Sanofi officials told him that the vaccines were ready.

On Dec. 10, 2015, then Health Secretary Janette Garin submitted a proposal to the Department of Budget and Management (DBM) for health facilities enhancement program (HFEP) funding and procurement of dengue vaccines.

On Dec. 23, a memorandum was issued by then Budget Secretary Florencio Abad to fund projects from the Miscellaneous Personnel Benefits Fund (MPBF) and Pension Gratuity Fund (PGF) savings. Among the projects identified was the dengue vaccination program.

On Dec. 29, a Special Allotment Release Order (SARO) was issued by the DBM to the DOH, obligating P3.5 billion for the vaccination program.

Aquino explained that savings had to be used to purchase the vaccines, because if not, “you are practically saying that the first implementation of this vaccine will be in 2017 because it will be for the next budget cycle, which will be under the new administration.”

He also said there was no guarantee the vaccines will be administered considering a “learning curve” at the start of every presidency.

“The choice is simple. We can implement it at this point in time for the protection – or wait at least a year as minimum and expose our people to a risk that could have been prevented because of this vaccine,” he added.

Aquino, in his opening statement, said before he approved the purchase of Dengvaxia, while he was still deciding, and even after he decided, no one protested.

He said Dengvaxia was given to 830,000 children in Metro Manila, Calabarzon and Central Luzon because data from the Department of Health showed that they were the regions most affected by dengue in 2015.

He said if he let his “bosses” suffer despite the existence of the vaccines, his critics would then accuse him of negligence.

Aquino said his administration began to focus on dengue after receiving a memorandum from former health secretary Enrique Ona dated Aug. 23, 2010, which highlighted the prevalence of dengue in five regions affecting around 2.8 million people.

He said two of the regions had more than 100 percent increase in dengue cases. Another, he said, had a 1,409.5 percent rise in cases.

Aquino said the vaccine went through “local and international processes.”

He said he was told that the US Food and Drug Administration regulates international clinical trials and that Dengvaxia underwent the process.

Besides, it was not only the Philippines that approved the administration of vaccines.  He said Mexico and Brazil did as well.

The vaccination program began on April 2016, just a month before the May presidential elections.

He said when he approved the purchase of the vaccines, he was not aware of the controversial issues faced by Sanofi Pasteur.

Senate blue ribbon committee chair Richard Gordon, during the hearing, enumerated a list of charges against Sanofi in other parts of the world.

He cited an instance back in 2012 when Sanofi was fined $109 million in the United States for violating the False Claims Act. Sanofi was also accused of bribery in several instances in the past.

Gordon also said there was a rush to buy Dengvaxia and that the vaccines were nearing expiration when they are purchased. He said the earlier expiry date was September 2017.

Sanofi officials said the vaccines had more than 18 months of life, which means they comply with DOH requirements.

Former health secretary Paulyn Ubial told the Senate hearing that she was under a lot of pressure from local officials after she halted dengue vaccination when she become health chief.

Ubial said among those who pressured her into introducing Dengvaxia was Garin’s husband, Iloilo Rep. Oscar Garin Jr. She said Cebu Rep. Gwendolyn Garcia badgered her into including Region VII in the dengue vaccination program. 

She linked her non-confirmation in the Commission on Appointments to the Dengvaxia fiasco.
 
NO PANIC

Thomas Triomphe, the head of Sanofi Pasteur for the Asia-Pacific region, said Dengvaxia continues to be safe and effective in providing persistent protection against the dengue infection.

Triomphe told senators that there is no “world-wide” scare over the Dengvaxia vaccine, which continues to be marketed and used in 10 other countries.

He also said there is no intent to downplay the risks of receiving the dengue vaccine if one had not been infected by the virus.

“There was no intent to downplay, there was an intent to clarify,” Triomphe said. “When we used the word ‘severe dengue,’ it’s not our choice. It’s the wording of severe dengue defined in the protocol of the clinical trial which was started in 2011.”

Triomphe said the word “severe” was too broad and constitutes different grades of classification.

He said Sanofi Pasteur is ready to “collaborate and reengage” with the Department of Health in contributing to the investigations to be done by the task forces on the review of the government’s dengue immunization program.

The World Health Organization yesterday advised member-states to limit the use of Dengvaxia to those previously infected with the dengue virus.

In a statement, the WHO said it is following the position of the Global Advisory Committee on Vaccine Safety based on the new evidence communicated by the vaccine’s manufacturer, Sanofi Pasteur.

“Dengvaxia prevents disease in the majority of vaccine recipients but it should not be administered to people who have not previously been infected with dengue virus,” said the WHO.

It noted how that latest findings of Sanofi Pasteur indicated an increase in incidence of hospitalization and severe illness in vaccinated children never infected with dengue.

Aside from limiting the target market for the dengue vaccine, the WHO said it is imperative for member-states that had approved the use of Dengvaxia to enhance its efforts to combat the disease.

President Duterte, on the eve of the testimony of former president Aquino in the Senate, said he has no plans of filing cases against former presidents.

Duterte said he would rather confront, or even shoot, political rivals for issues and misunderstandings rather than file a law suit.

Prior to his pronouncement, the President said he believed that the former administration undertook the dengue vaccine program in good faith.

Duterte said the program was implemented based on the information that the previous administration had and it was undertaken without knowledge that the latest controversy and questions about the safety of the Dengvaxia vaccine would surface. – With Jocelyn Montemayor and Gerard Naval
Category: 
Rating: 
No votes yet